CGPHF (Grand Pharmaceutical Group) PB Ratio: 0.00 (As of Jun. 27, 2026)


What is Grand Pharmaceutical Group PB Ratio?

Grand Pharmaceutical Group CGPHF 87 PB Ratio is 0.00 as of Jun. 27, 2026. GuruFocus rates CGPHF with a GF Score™ of 87/100. The stock has 6 warning signs investors should review. Among 922 Drug Manufacturers companies, Grand Pharmaceutical Group ranks better than 77.77% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-27), Grand Pharmaceutical Group's share price is $0.00. Grand Pharmaceutical Group's Book Value per Share for the quarter that ended in Dec. 2025 was $0.63. Hence, Grand Pharmaceutical Group's PB Ratio of today is 0.00.

Good Sign:

Grand Pharmaceutical Group Ltd stock PB Ratio (=0.99) is close to 1-year low of 0.99.

The historical rank and industry rank for Grand Pharmaceutical Group's PB Ratio or its related term are showing as below:

CGPHF' s PB Ratio Range Over the Past 10 Years
Min: 0.77   Med: 1.93   Max: 6.36
Current: 0.99

During the past 13 years, Grand Pharmaceutical Group's highest PB Ratio was 6.36. The lowest was 0.77. And the median was 1.93.

CGPHF's PB Ratio is ranked better than
77.77% of 922 companies
in the Drug Manufacturers industry
Industry Median: 1.825 vs CGPHF: 0.99

During the past 12 months, Grand Pharmaceutical Group's average Book Value Per Share Growth Rate was 3.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 6.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 8.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 24.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Grand Pharmaceutical Group was 335.80% per year. The lowest was -38.30% per year. And the median was 19.40% per year.

Back to Basics: PB Ratio


Grand Pharmaceutical Group  (OTCPK:CGPHF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Grand Pharmaceutical Group PB Ratio Related Terms


Grand Pharmaceutical Group PB Ratio Historical Data

* Premium members only.

The historical data trend for Grand Pharmaceutical Group's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grand Pharmaceutical Group PB Ratio Chart

Grand Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Grand Pharmaceutical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CGPHF vs ZTS: PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grand Pharmaceutical Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grand Pharmaceutical Group PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grand Pharmaceutical Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Grand Pharmaceutical Group's PB Ratio falls into.



Grand Pharmaceutical Group PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Grand Pharmaceutical Group's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=0.00/0.625
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 0.00 mean?
Grand Pharmaceutical Group (CGPHF) has a PB Ratio of 0.00 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Grand Pharmaceutical Group and its competitors. Over the past decade, Grand Pharmaceutical Group's PB Ratio has ranged from 0.77 to 6.36. According to the industry distribution chart, Grand Pharmaceutical Group ranks #205 out of 922 companies in the Drug Manufacturers industry, placing it in the top 22.2%.
Is Grand Pharmaceutical Group's PB Ratio too high?
Grand Pharmaceutical Group's current PB Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.77 to a high of 6.36. Based on the distribution chart, Grand Pharmaceutical Group ranks #205 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Grand Pharmaceutical Group has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Grand Pharmaceutical Group's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Grand Pharmaceutical Group ranks #205 out of 922 companies for PB Ratio. This places Grand Pharmaceutical Group in the top 22% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.83. Historically, Grand Pharmaceutical Group's own PB Ratio has ranged from 0.77 to 6.36 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Grand Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Pharmaceutical Group's current PB Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Pharmaceutical Group stock overvalued right now?
Grand Pharmaceutical Group (CGPHF) has a current PB Ratio of 0.00. The current PB Ratio is 0.00. Grand Pharmaceutical Group's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Grand Pharmaceutical Group (CGPHF), the current PB Ratio is 0.00 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grand Pharmaceutical Group Business Description

Other Exchanges 00512:Hong KongMX6A:Germany
Address 99 Queen\'s Road Central, Units 3302, 33rd Floor, The Center, Hong Kong, HKG
Grand Pharmaceutical Group Ltd are principally engaged in the manufacture and sales of pharmaceutical technology products, manufacture and sales of bio-technology products as well as manufacture and sales of nuclear medicine anti-tumor diagnosis and treatment and cerebro-cardiovascular precision interventional diagnosis and treatment technology products, in the People's Republic of China. The operation of the group constitutes one single reportable segment. The company has presence in The PRC, America, Europe, Asia other than the PRC and Others. The majority of revenue comes from the PRC. Its brands are breathe, biology, Cardiovascular emergency care, Cardiovascular intervention, ENT, tumor.